Neuropace, Inc. NPCE Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s accrued manufacturing costs?
- Neuropace, Inc. (NPCE) reported accrued manufacturing costs of $7M in Q1 2026.
- How has Neuropace, Inc.'s accrued manufacturing costs changed year-over-year?
- Neuropace, Inc.'s accrued manufacturing costs increased by 18.4% year-over-year, from $5.91M to $7M.
- What is the long-term trend for Neuropace, Inc.'s accrued manufacturing costs?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s accrued manufacturing costs has grown at a 18.1% compound annual growth rate (CAGR), from $4.57M to $10.49M.